Categories: FAANG

Immunai Co-Founder Luis Voloch on Using Deep Learning to Develop New Drugs

Mapping the immune system could lead to the creation of drugs that help our bodies win the fight against cancer and other diseases. That’s the big idea behind immunotherapy. The problem: the immune system is incredibly complex.

Enter Immunai, a biotech company that’s using cutting-edge genomics & ML technology to map the human immune system and develop new immunotherapies against cancer and autoimmune diseases.

On this episode of NVIDIA’s AI Podcast, host Noah Kravitz spoke with Luis Voloch, co-founder and CTO of Immunai, about tackling the challenges of the immune system with a machine learning and data science mindset.

You Might Also Like

Artem Cherkasov and Olexandr Isayev on Democratizing Drug Discovery With NVIDIA GPUs

It may seem intuitive that AI and deep learning can speed up workflows — including novel drug discovery, a typically years-long and several-billion-dollar endeavor. However, there is a dearth of recent research reviewing how accelerated computing can impact the process. Professors Artem Cherkasov and Olexandr Isayev discuss how GPUs can help democratize drug discovery.

Lending a Helping Hand: Jules Anh Tuan Nguyen on Building a Neuroprosthetic

Is it possible to manipulate things with your mind? Possibly. University of Minnesota postdoctoral researcher Jules Anh Tuan Nguyen discusses allowing amputees to control their prosthetic limbs with their thoughts, using neural decoders and deep learning.

Wild Things: 3D Reconstructions of Endangered Species with NVIDIA’s Sifei Liu

Studying endangered species can be difficult, as they’re elusive, and the act of observing them can disrupt their lives. Sifei Liu, a senior research scientist at NVIDIA, discusses how scientists can avoid these pitfalls by studying AI-generated 3D representations of these endangered species.

Subscribe to the AI Podcast: Now Available on Amazon Music

You can now listen to the AI Podcast through Amazon Music.

Also get the AI Podcast through iTunes, Google Podcasts, Google Play, Castbox, DoggCatcher, Overcast, PlayerFM, Pocket Casts, Podbay, PodBean, PodCruncher, PodKicker, Soundcloud, Spotify, Stitcher and TuneIn.

Make the AI Podcast better: Have a few minutes to spare? Fill out our listener survey.

 

The post Immunai Co-Founder Luis Voloch on Using Deep Learning to Develop New Drugs appeared first on NVIDIA Blog.

AI Generated Robotic Content

Recent Posts

REFACTOR-VLA: Unsupervised Library Learning of Typed Motor Programs

Most current vision-language-action (VLA) models—such as OpenVLA, π0, RT-2, and RDT-1B—are “monolithic.” This means they…

3 hours ago

Accessing OpenAI models on Amazon Bedrock from Australia with global cross-Region inference

Australian teams working with OpenAI models can now access the latest OpenAI models through Amazon…

3 hours ago

Getting started with Mantis, our open-source bug finding-and-fixing harness

AI models have clearly proven their ability to discover and exploit vulnerabilities without much, if…

3 hours ago

Meta Pushes Its New AI Agent on Employees—but Eases Off on Tokenmaxxing

The company is reducing pressure on workers to use artificial intelligence tools while encouraging them…

4 hours ago

Why did your robotaxi stop? New system helps predict self-driving car mistakes

Self-driving cars are often controlled by deep learning models that sometimes fail in unexpected situations.…

4 hours ago

Introducing Claude Fable 5.1 on AWS

Today, we’re excited to announce the availability of Claude Fable 5.1 on Amazon Bedrock and…

1 day ago